A deal to have Kodak produce pharmaceuticals is now on hold, but some big investors have already cashed out. Wall Street Journal Investing Editor Geoffrey […]
Continue readingA deal to have Kodak produce pharmaceuticals is now on hold, but some big investors have already cashed out. Wall Street Journal Investing Editor Geoffrey […]
Continue reading